| SIU School of Medicine

News

AFSCME, SIU School of Medicine ink 3-year agreement

SIU School of Medicine and AFSCME Local 370 have finalized and ratified a new collective bargaining agreement, effective July 1, 2025, through June 30, 2028. The union represents more than 800 school employees across its campuses.

News

AFSCME, SIU School of Medicine ink 3-year agreement

SIU School of Medicine and AFSCME Local 370 have finalized and ratified a new collective bargaining agreement, effective July 1, 2025, through June 30, 2028. The union represents more than 800 school employees across its campuses.

News

AFSCME, SIU School of Medicine ink 3-year agreement

SIU School of Medicine and AFSCME Local 370 have finalized and ratified a new collective bargaining agreement, effective July 1, 2025, through June 30, 2028. The union represents more than 800 school employees across its campuses.

News

AFSCME, SIU School of Medicine ink 3-year agreement

SIU School of Medicine and AFSCME Local 370 have finalized and ratified a new collective bargaining agreement, effective July 1, 2025, through June 30, 2028. The union represents more than 800 school employees across its campuses.

General Results

Student handbook PA program

This handbook will help you learn more about the SIU PA Program's mission, goals, and competencies. Within this manual, you will find an overview of the entire curriculum, the Program's honor and conduct codes, Student Progress documents, exit objectives, and forms you may need during Phase I, II and III. The content in this handbook is considered accurate; however, the Program may change specific procedures and guidelines after the handbook is completed. These changes will supersede what is contained in the handbook, and you will be responsible for complying with them. The Program will make

Trial

Internal Medicine

AstraZeneca BaxPA: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Baxdrostat in Adult Participants with Primary Aldosteronism

Active recruiting

The purpose of this clinical trial is to learn more about a new, investigational, once daily medication, called baxdrostat, and its ability to lower blood pressure in individuals diagnosed with primary aldosteronism.

Eligible patients include those who currently have a diagnosis of high blood pressure, specifically primary aldosteronism, despite having taken or are currently taking anti-hypertensive medications.

Trial

Simmons Cancer Institute

(2024-02) Specimen Collection from Participants Due for Colorectal Cancer Screening, Surveillance, or Treatment: IMPACT

Active recruiting

This study aims to collect health information along with blood and stool samples (and urine and/or saliva, if applicable) to assist in the development of colorectal cancer screening test(s). Individuals having a colonoscopy (with or without a diagnosis of colorectal cancer) are potentially eligible.

Profiles

Heather Oldani

Fellowship Coordinator

Addiction Medicine Fellowship

News

The doctors behind the smiles

When a child is born with a cleft lip or palate, SIU Medicine surrounds families with a team devoted to expert care and compassion, from a baby’s first breath to a teen’s final surgery. Our specialists walk alongside families, providing clarity, confidence and lifelong support every step of the way.

News

The doctors behind the smiles

When a child is born with a cleft lip or palate, SIU Medicine surrounds families with a team devoted to expert care and compassion, from a baby’s first breath to a teen’s final surgery. Our specialists walk alongside families, providing clarity, confidence and lifelong support every step of the way.